AMRN logo

AMRN Amarin Corporation plc

NASDAQ Global Market · Drug Manufacturers - General · Healthcare

$11.26
+0.00 (+0.00%)

Amarin Corporation plc is a pharmaceutical firm dedicated to the research, development, and commercialization of therapeutic solutions for cardiovascular diseases. Its operations span several international regions, including the United States, Germany, Canada, Lebanon, and the United Arab Emirates. The company's flagship product is VASCEPA, an omega-3 fatty acid formulation available by prescripti…

Market Cap: $237.38Mwww.amarincorp.com

Price

No data yet.

Social Signal Score

48
5d
—
30d
50
6 mentions
—
60d
50
6 mentions
—
90d
45
9 mentions
—
news: 9

Analyst Ratings

18 analysts
Holdconsensus
Strong Buy 0Buy 3Hold 13Sell 2Strong Sell 0
Avg price target$2.17-80.7%
Low $1.5Median $2High $3
Current Consensus

Revenue

$39.55M+2.21%
$34.64M$78.84M$123.05M$167.25M
Dec 2016Sep 2026

Analyst Estimates

FY2025
$-0.66
$-2.12–$0.80
1 analysts
FY2026
$-1.13
$-1.15–$-1.11
1 analysts
FY2027
$-0.63
$-0.64–$-0.62
1 analysts

Consensus estimates, not results. Via Financial Modeling Prep.

Company Profile

CEO
Aaron D. Berg
Sector
Healthcare
Industry
Drug Manufacturers - General
Employees
80
Beta
0.79
Country
IE
Piotroski score
4 / 9 (Middling)
Altman Z-score
-2.06
www.amarincorp.com